Still's disease: paediatrics to adults, a continuum or not?
Dr. Ilenia Di Cola and Dr. Piero Ruscitti
Jul 25, 2022
Blogs
Still’s disease is a rare inflammatory disorder, affecting less than 1 person per 2000 people. This disease may occur in both children and adults, namely as systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD).
The paediatric form was described by George Still in 1896, whereas the adult variant later by Eric Bywaters in 1971. However only the adult disease is identified by the name of Still.
The Still’s Continua
Jul 20, 2022
The concept of a “Still’s disease continuum” that encompasses both sJIA and AOSD is based on the many common clinical, genetic and laboratory features shared by both sJIA and AOSD.
Best of 2021: Drug Safety Risk Communication- The 800 lb Gorilla Approach
Dec 28, 2021
Discussions on drug safety can be as treacherous as quicksand for the patient and physician. What the physician knows and what the patient perceives may not be in sync.
ICYMI: Drug Safety Risk Communication- The 800 lb Gorilla Approach
Sep 30, 2021
Discussions on drug safety can be as treacherous as quicksand for the patient and physician. What the physician knows and what the patient perceives may not be in sync.
Three Healthcare Hashtags You Should Follow
Sep 14, 2021
Pearls Part 2: Common Sense Rheumatology
Dec 03, 2019
A Review of the Review Course + How to Make the Information Stick
Nov 25, 2019
Best of 2018: 5 Mistakes When Diagnosing Adult-Onset Still’s Disease
Dec 28, 2018
Adult-onset Still's presents an interesting and diagnostic challenge when encountered. Here are 5 tips to improve your diagnostic acumen for this febrile disorder.
Advice for Young Rheumatologists
Nov 21, 2018
You may not want my advice, but I’m going to give it to you anyway.
Prescription Drugs and the Effect on Access to Biosimilars in the US
Jul 10, 2018
Best of 2017: Rules for Drug Cessation with Infection
Jul 03, 2018
Everyone gets their education about drug-related infection risk from television ads. Rheumatologists should know what the real risks are and educate their patients that they have a higher than normal rate of nonserious infections. But the infection risk is way more related to inflammation than any specific drug risk.
Throw Me Rope
Apr 10, 2018
A gal with rheumatoid arthritis moved to my town and has transferred her care to me. Despite having RA for 3 years and swollen joints at the last three visits, she has taken surprisingly few effective drugs thus far.
On this visit I declared my concerns for her future health, especially if we didn’t make significant changes in therapy. So I recommended she start a new drug. She asked several good questions, then stated she wanted to go home and think about this further and she would get back to me with her decision.
But wait, that’s what she said at her last visit 2 months ago!